Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gastrointestinal 1

Conditions

Uveal Melanoma 1Sarcoma 1Pleural Neoplasms 1Mediastinal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Doxorubicin 14Specimen Handling 12pembrolizumab 11Magnetic Resonance Spectroscopy 10Biopsy 10Cyclophosphamide 9X-Rays 7Radiotherapy 7Ifosfamide 7Phantoms, Imaging 6Nivolumab 6Gemcitabine 6tazemetostat 5liposomal doxorubicin 5Temozolomide 5Radiation 5palbociclib 4fludarabine 4Nuclear Medicine Department, Hospital 4Irinotecan 4larotrectinib 3cabozantinib 3atezolizumab 3Trabectedin 3Surveys and Questionnaires 3Radiation Dose Hypofractionation 3Proton Therapy 3Ipilimumab 3Carboplatin 3Bevacizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × Iodized Oil × 90 days × Clear all
NCT05672108 2026-03-05

Phase II Trial of Lung Chemoemobolization

City of Hope Medical Center

Phase 2 Recruiting
30 enrolled
GastrointestinalSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Mediastinal Neoplasms, Pleural Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡